WA
DMK

WFG Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

WFG Advisors’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-57
Closed -$17K – 1736
2015
Q2 		$17K Buy
57
+14
+33% +$4.23K ﹤0.01% 1038
2015
Q1 		$12K Hold
43
– – ﹤0.01% 1158
2014
Q4 		$19K Hold
43
– – ﹤0.01% 1251
2014
Q3 		$14K Hold
43
– – ﹤0.01% 1391
2014
Q2 		$14K Hold
43
– – ﹤0.01% 1396
2014
Q1 		$19K Buy
+43
New +$19.5K ﹤0.01% 1278

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WFG Advisors's DMK Position: Q3 2015 in Review

WFG Advisors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2015, closing a stake of 57 shares — an estimated $17K sold.

WFG Advisors first reported a position in DMK in Q1 2014 and held it in 6 quarters. The position peaked at $19K in Q4 2014. 28 funds tracked by Wall St. Rank hold DMK as of Q3 2015.

  • WFG Advisors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2015 after selling out during the quarter.
  • WFG Advisors sold 57 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2015, an estimated $17K.
  • WFG Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 6 quarters.
  • WFG Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $19K in Q4 2014.
  • 28 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2015.

Based on WFG Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.